直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

INCONTESTABLE® Blog

Manufacturer That Sold Copied Goods Not Liable for Reverse Passing Off

August 18, 2015

Authored and Edited by Jonathan D. Uffelman; Naresh Kilaru; Julia Anne Matheson

On August 5, 2015, the Sixth Circuit held that a manufacturer selling copied goods was not liable for false designation of origin under a reverse passing off theory.

Best Lighting Products designed and sold exit signs and emergency lighting products for commercial buildings, and Pace Electronic Products manufactured fully assembled products for Best.  Because Pace had never manufactured emergency lighting products before, Best expended significant effort teaching Pace how to manufacture the tooling necessary to make the products according to Best’s specifications.  However, as it filled orders for Best, Pace began using the same tooling to manufacture thousands of additional cloned units, which Pace then sold under its own name, often to Best’s established customers. 

The district court concluded as a matter of law that Pace had, among other things, violated the Lanham Act both with respect to false designation of origin (reverse passing off) and false advertising.  Pace appealed, and the Sixth Circuit reversed.

Reverse passing under Lanham Act Section 43(a) occurs when a person falsely designates the “origin” of someone else’s goods or services, misrepresenting them as its own.  The district court concluded that Pace falsely designated the cloned products’ “origin” by failing to represent to its customers that the products stemmed from ideas or intellectual property that originated with Best.

The problem with the district court’s finding, according to the Sixth Circuit, is that the Lanham Act protects the ability to control one’s brand, not one’s inventions or innovations.  Thus, in the context of a reverse passing off claim, the Act’s use of the term “origin” refers only to the product’s physical origin, not its intellectual ancestry.  Here, it was undisputed that Pace manufactured the cloned products.  Because the physical products themselves originated with Pace, Pace never made a false designation of the products’ “origin” within the meaning of Section 43(a), even though the ideas and initial design may have originated with Best.

Ultimately, protection against imitation of product design is found in copyright and patent law.  The Sixth Circuit did not allow Best to use a false-designation Lanham Act claim as a substitute for failing to have a protectable intellectual property right in the products:  “Regardless of whether Pace’s conduct was prohibited under other legal regimes, it was not prohibited by the Lanham Act.”

Tags

false advertising, Section 43(a)

Contacts

Jonathan D. Uffelman
Domain Name Specialist / Attorney
Washington, DC
+1 202 408 4328
Email
Naresh Kilaru
Partner
Washington, DC
+1 202 408 4236
Email

Copyright © 2015 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Conference

IP Life Sciences Forum 2026

December 13-15, 2026

Coral Gables

Conference

4th Global Patent Litigation FORUM

October 29, 2026

Munich

Conference

2nd Annual Forum on Pharma & Biotech Patent Litigation USA & Canada

October 14-16, 2026

New York

Reception

CONNECTails: Networking for Biotech Entrepreneurs & Investors

September 17, 2026

Rockville

At the PTAB Blog

Federal Circuit PTAB Appeal Statistics for June and July 2026

September 9, 2026

Articles

A “Side Bet” Option Does Not Create a Live Case or Controversy on Appeal

September 9, 2026

Articles

California Brings First CCPA and Delete Act Enforcement Action Against Data Broker

September 4, 2026

Webinar

U.S. Discovery for Foreign Proceedings—28 USC § 1782 Requirements and Practice Tips

September 2, 2026

Webinar

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in June and July 2026

August 19, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP